Medication vs. Surgery for Better Liver Graft Flow
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a medication (octreotide) or a minor surgical procedure (tying off a spleen artery) works better to help a smaller-than-ideal liver graft work well after a living donor transplant. The goal is to improve blood flow and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 69 years old.
- You are scheduled for a living donor liver transplant.
- Your doctor says you need a special treatment because the donated liver part is smaller than usual for your body.
- You do not have a known allergy to octreotide or similar medications.
- You are not pregnant.
- You are not receiving a deceased donor or a dual transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests an injection of lab-grown liver cells into the stomach muscle to prevent or treat small-for-size syndrome, a condition where a partial liver graft is too small. It may also help people with acute or chronic liver failure.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This study tests whether a special way of moving blood through the donor abdomen before surgery can improve liver (and other organ) transplant quality. It may help because doctors can check how well the liver seems to be working before it’s actually used.
This trial tests if giving less fluid during liver transplant surgery helps recovery. It is for adults with end-stage liver disease receiving a transplant.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
Hear when a new Small-for-Size Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.